PRODUCT DEVELOPMENT SERVICES
Clinical Pharmacodynamics

In recent years there has been increasing interest in the application of biomarkers and surrogate endpoints in healthy volunteer studies to provide pivotal information on efficacy, dose-response and time-effects of drugs. ICON has worked extensively in this area, developing and validating models for investigating a range of therapeutic targets, as part of its own research and development efforts and in partnership with Sponsors.

Current Models Include:

Acute Pain
  •    Cold Pain Test
  •    Heat Pain Detection Threshold
  •    Heat Pain Tolerance
  •    Brief Thermal Stimulation
Chronic Pain
  •    Intradermal Capsaicin Model
    •    Hyperalgesia
    •    Allodynia
    •    Pain VAS
    •    Flare Measurement
    •    Heat Hyperalgesia
  •    Topical Capsaicin Model
  •    Heat Capsaicin Model
  •    Quantitative Sensory Testing (QST)
    •    Perception Thresholds
    •    Heat detection
    •    Cold detection
    •    Wind up ratio
    •    Mechanical pain threshold/sensitivity
    •    Pressure pain threshold
  •    UVB/C Burn Model (in development)
Inflammatory Response
  •    Cantharidin Blister Model
Anxiety Models
  •    Simulated Public Speaking
  •    Aversive Conditioning
  •    CO2 - Induced Anxiety
Test Meal Model
  •    Universal Eating Monitor
  •    Validated Questionnaires
  •    Bioelectrical Impedence
  •    Food Diaries
Diabetes
  •    Glucose Clamp
Sexual Dysfunction
  •    Ejaculatory Latency Model
Cognition
  •    Scopolamine Model